FLT3-TKD mainly includes the FLT3D835Y substitution and is found in ~ 7% of patients with AML [20, 21], FLT3 mutations could serve as important diagnostic and prognostic markers for AML. This evidence concerns the gene FLT3 and acute myeloid leukemia.